CCT3 has been involved in mitosis progression and associated with poor prognosis in hepatocellular carcinoma [33], has been implicated in osteosarcoma tumorigenesis [34], and appeared as a candidate biomarker in epithelial ovarian cancer [35] and in cholangiocarcinoma patients [36]. The gene discussed is CCT3; the disease is cholangiocarcinoma.